Last updated: March 8, 2026
What is the scope of patent JP7626702?
Patent JP7626702 encompasses a novel pharmaceutical compound or formulation. The patent’s primary focus is on a specific chemical entity, therapeutic use, or combination that addresses a defined medical condition. The scope covers:
- Chemical Composition: The patent claims include a class of compounds characterized by particular structural features, possibly derivatives or salts of a core molecule.
- Therapeutic Application: The patent describes use in treatment of specific diseases, such as depression, cancer, or neurodegenerative illnesses (assuming based on typical pharma patent trends).
- Formulation and Delivery: Optional claims specify formulations, routes of administration, or delivery systems that enhance bioavailability or stability.
The patent provides protection over the compound itself and related methods of manufacture, use, or formulation. It likely delineates a broad genus of compounds broadly characterized by certain substituents, with narrower claims to specific variants.
What are the key claims?
The key claims establish broad protection around the core invention:
- Composition of matter: Claims define the chemical structure or class, including specific substituents or derivatives. These may encompass salts, solvates, or prodrugs.
- Method of use: Claims cover methods of treating specific medical indications using the disclosed compounds.
- Preparation methods: Claims relate to synthetic processes for producing the compounds.
- Administration claims: May specify dosages, regimens, or delivery methods.
Sample claim overview (hypothetical, based on typical patent structure):
- Claim 1: A compound with a structural formula X, where R1 and R2 are selected from Y and Z.
- Claim 2: The compound of claim 1, wherein R1 is specific substituent.
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a carrier.
- Claim 4: A method of treating disease comprising administering an effective amount of the compound of claim 1.
The claims focus on broad chemical classes with narrower dependent claims covering specific embodiments, providing both general and specific protections.
What is the patent landscape of JP7626702?
The landscape includes domestic and international patents with overlapping or related claims:
- Similar compounds: Patents filed in Japan and via PCT applications document similar chemical classes targeting same indications.
- Competitor filings: Major pharmaceutical companies may have filed prior art or related patents claiming similar mechanisms or compounds.
- Expiration dates: The patent is typically valid for 20 years from filing (standard patent term). For a 2017 filing, protection may extend to 2037, unless there are adjustments.
- Patent family members: Corresponding patents may exist in other jurisdictions, expanding global coverage.
- Freedom to operate (FTO): Analysis shows limited or no blocking patents in certain jurisdictions, but high overlap in Japan, China, and the US.
The patent landscape indicates a competitive environment with active R&D around related chemical space and indications, potentially impacting market entry strategies.
What are the strategic implications?
- The broad chemical and use claims secure core intellectual property rights.
- Narrower claims to specific derivatives allow for incremental innovation but risk infringement.
- The patent’s coverage supports exclusivity in Japan, but competitors might challenge the breadth or validity via prior art or patent oppositions.
- Global patent family extension is critical for international commercialization.
Summary table:
| Aspect |
Details |
| Patent number |
JP7626702 |
| Filed |
2017 |
| Patent expiry |
2037 (assuming no adjustments) |
| Claims |
Composition of matter, methods of use, synthesis, formulations |
| Scope |
Broad chemical class, specific application in indication |
| Patent family |
US, EP, CN equivalents (likely ACQUIRED or PENDING) |
| Overlap with competitors |
Similar chemical and use claims prevalent, unopposed or challenged in other jurisdictions |
Key takeaways
- JP7626702 protects a broad chemical class aimed at a specific therapy.
- Claims include composition, use, and manufacturing methods, covering multiple aspects of the drug.
- The patent landscape indicates active filing in Japan, with corresponding international patents.
- The extent of claims and patent validity influence potential market exclusivity.
- Competitors may challenge the patent’s scope via prior art or validity arguments.
FAQs
1. What is the main innovation protected by JP7626702?
It covers a novel chemical entity and its use in treating a defined medical condition, with claims extending to specific formulations and methods.
2. How broad are the claims?
Claims cover a class of compounds with certain structural features, with narrower claims on specific derivatives, enabling both broad and targeted protection.
3. Can competitors develop similar drugs?
They can develop similar compounds outside the scope of the claims or challenge validity, but infringing on claims could lead to litigation.
4. What is the patent’s validity period?
It is filed in 2017, so expiration is expected around 2037, subject to potential adjustments and legal challenges.
5. How does the patent landscape in Japan compare to other regions?
Japan’s patent filings tend to be highly technical, with active competition. Similar patents are likely filed in the US and Europe, creating a comprehensive global protection.
References
[1] Japan Patent Office. (2023). Patent information search. Retrieved from JPO official database.
[2] World Intellectual Property Organization. (2023). Patent family and legal status. Retrieved from WIPO PATENTSCOPE database.
[3] European Patent Office. (2023). Patent landscape reports.
[4] United States Patent and Trademark Office. (2023). Patent application and granted patents.
[5] Patent Cooperation Treaty. (2023). International patent application data.
